FDA — authorised 13 November 1967
- Application: NDA016418
- Marketing authorisation holder: WYETH PHARMS
- Local brand name: INDERAL
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Inderal in United States
FDA authorised Inderal on 13 November 1967
Marketing authorisations
FDA — authorised 19 April 1983
- Application: NDA018553
- Marketing authorisation holder: ANI PHARMS
- Local brand name: INDERAL LA
- Indication: CAPSULE, EXTENDED RELEASE — ORAL
- Status: approved
FDA — authorised 12 December 1986
- Application: NDA019536
- Marketing authorisation holder: WYETH AYERST
- Local brand name: INDERAL
- Indication: SUSPENSION — ORAL
- Status: approved
FDA
- Status: approved
Inderal in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Inderal approved in United States?
Yes. FDA authorised it on 13 November 1967; FDA authorised it on 19 April 1983; FDA authorised it on 12 December 1986.
Who is the marketing authorisation holder for Inderal in United States?
WYETH PHARMS holds the US marketing authorisation.